분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2014-02-22 04:09:47 , Hit : 2105
 Genetically Altered Stem Cells Generate Engineered Cartilage


GEN News Highlights
More »
Feb 19, 2014

Genetic Engineering & Biotechnology News (2/19)

Duke University researchers say they have moved a step closer to being able to generate replacement cartilage where it’s needed in the body by combining a synthetic scaffolding material with gene delivery methods.

Initiating tissue repair with stem cells usually requires the use of large amounts of growth factors. Experience has demonstrated that this is expensive and can be challenging once the developing material is implanted within a body.

In a new study (“Scaffold-mediated lentiviral transduction for functional tissue engineering of cartilage”) in PNAS, the Duke team found a way around this limitation by genetically altering the stem cells to make the necessary growth factors all on their own.

They incorporated viruses used to deliver gene therapy to the stem cells into a synthetic material that serves as a template for tissue growth. The resulting material is like a computer; the scaffold provides the hardware and the virus provides the software that programs the stem cells to produce the desired tissue.

Farshid Guilak, Ph.D., director of orthopedic research at Duke University Medical Center, notes that one challenge he and all biomedical researchers face is getting stem cells to form cartilage within and around the scaffolding, especially after it is implanted into a living being. The traditional approach has been to introduce growth factor proteins, which signal the stem cells to differentiate into cartilage. Once the process is under way, the growing cartilage can be implanted where needed.

“But a major limitation in engineering tissue replacements has been the difficulty in delivering growth factors to the stem cells once they are implanted in the body,” explains Dr. Guilak, who is also a professor in Duke’s department of biomedical engineering. So they developed a new approach.

“The goal of this study was to generate a self-contained bioactive scaffold capable of mediating stem cell differentiation and formation of a cartilaginous extracellular matrix (ECM) using a lentivirus-based method,” write the investigators. “We first showed that poly-L-lysine could immobilize lentivirus to poly(ε-caprolactone) films and facilitate human mesenchymal stem cell (hMSC) transduction. We then demonstrated that scaffold-mediated gene delivery of transforming growth factor β3 (TGF-β3), using a 3D woven poly(ε-caprolactone) scaffold, induced robust cartilaginous ECM formation by hMSCs.”

While this study focuses on cartilage regeneration, the Duke researchers believe the technique could be applied to many kinds of tissues, especially orthopedic tissues such as tendons, ligaments, and bones. And because the platform comes ready to use with any stem cell, it presents an important step toward commercialization.

“One of the advantages of our method is getting rid of the growth factor delivery, which is expensive and unstable, and replacing it with scaffolding functionalized with the viral gene carrier,” points out Charles Gersbach, Ph.D., an assistant professor of biomedical engineering and an expert in gene therapy. “The virus-laden scaffolding could be mass-produced and just sitting in a clinic ready to go. We hope this gets us one step closer to a translatable product.”








847   CRISPR Reverses Disease Symptoms in Living Animals for First Time  이성욱 2014/04/01 1685
846   약물 생산을 보다 저렴하고 환경친화적으로 만드는데 도움을 주는 바이오 역합성  이성욱 2014/03/26 2112
845   J&J-Medivir Drug for Hepatitis C Recommended by EU Regulator  이성욱 2014/03/24 2017
844   스트레스를 받는 뇌세포는 알츠하이머로부터 보호작용을 한다  이성욱 2014/03/24 1928
843   RNA 치료제 등 3대 R&D 트렌드  이성욱 2014/03/18 2016
842   막다른 골목에 몰린 STAP 세포  이성욱 2014/03/18 1930
841   암 세포의 혈관 밖 이동을 돕는 자외선  이성욱 2014/03/13 2166
840   유전자 편집방법을 이용한 HIV 치료  이성욱 2014/03/10 2081
839   Merck hepatitis C drugs work in HIV co-infected patients -study  이성욱 2014/03/08 1729
838   Gene Therapy for Controlling HIV Shows Early Promise  이성욱 2014/03/08 1659
837   Fragile X syndrome: Trigger for most common form of intellectual disability and autism uncovered  이성욱 2014/03/05 1816
836   인체 '게놈 분석 1000달러 시대' 왔다  이성욱 2014/02/28 2110
835   FDA Gives Bristol-Myers' Hepatitis Drug 'Breakthrough' Designation  이성욱 2014/02/26 2038
834   숙주 세포 핵의 바아러스 DNA 분해  이성욱 2014/02/26 2275
  Genetically Altered Stem Cells Generate Engineered Cartilage  이성욱 2014/02/22 2105
832   자궁경부암 유발 바이러스에도 효과를 보이는 HIV 약물  이성욱 2014/02/21 2403
831   美 연구팀, ‘원숭이 아바타’ 실험 성공시켰다  이성욱 2014/02/20 2126
830   Small non-coding RNAs could be warning signs of cancer  이성욱 2014/02/18 1809
829   Gilead submits fixed-dose combination ledipasvir/sofosbuvir HCV tablet for FDA approval  이성욱 2014/02/12 2386
828   Researchers turn adult cells back into stem cells  이성욱 2014/01/30 1663

[이전 10개] [1]..[21] 22 [23][24][25][26][27][28][29][30]..[64] [다음 10개]
 

Copyright 1999-2024 Zeroboard / skin by ROBIN